A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

NCT07425821 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

112

Enrollment

NETWORK

Sponsor class

Conditions

Marburg Virus Disease

Interventions

BIOLOGICAL: rVSV∆G-MARV-GP
OTHER: Placebo

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]